KR
Therapeutic Areas
Asklepion Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| IV L-citrulline | Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Congenital Heart Defects | Phase 3 |
| Cholbam (cholic acid) | Bile Acid Synthesis Defects (e.g., peroxisomal disorders including Zellweger spectrum disorders) | Approved |